Seliger B - Search Results

1

What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past.

Yao Y, Liang H, Fang X, Zhang S, Xing Z, Shi L, Kuang C, Seliger B, Yang Q. Yao Y, et al. Among authors: seliger b. J Exp Clin Cancer Res. 2021 Feb 8;40(1):60. doi: 10.1186/s13046-021-01847-4. J Exp Clin Cancer Res. 2021. PMID: 33557876 Free PMC article. Review.

2

IFN inducibility of major histocompatibility antigens in tumors.

Seliger B, Ruiz-Cabello F, Garrido F. Seliger B, et al. Adv Cancer Res. 2008;101:249-76. doi: 10.1016/S0065-230X(08)00407-7. Adv Cancer Res. 2008. PMID: 19055946 Free PMC article. Review.

3

Altered detoxification status and increased resistance to oxidative stress by K-ras transformation.

Recktenwald CV, Kellner R, Lichtenfels R, Seliger B. Recktenwald CV, et al. Among authors: seliger b. Cancer Res. 2008 Dec 15;68(24):10086-93. doi: 10.1158/0008-5472.CAN-08-0360. Cancer Res. 2008. PMID: 19074874

4

Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.

Respa A, Bukur J, Ferrone S, Pawelec G, Zhao Y, Wang E, Marincola FM, Seliger B. Respa A, et al. Among authors: seliger b. Clin Cancer Res. 2011 May 1;17(9):2668-78. doi: 10.1158/1078-0432.CCR-10-2114. Epub 2011 Jan 19. Clin Cancer Res. 2011. PMID: 21248298 Free PMC article.

5

Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity.

Seliger B. Seliger B. Front Immunol. 2019 May 22;10:999. doi: 10.3389/fimmu.2019.00999. eCollection 2019. Front Immunol. 2019. PMID: 31178856 Free PMC article. Review.

6

Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy.

Friedrich M, Jasinski-Bergner S, Lazaridou MF, Subbarayan K, Massa C, Tretbar S, Mueller A, Handke D, Biehl K, Bukur J, Donia M, Mandelboim O, Seliger B. Friedrich M, et al. Among authors: seliger b. Cancer Immunol Immunother. 2019 Oct;68(10):1689-1700. doi: 10.1007/s00262-019-02373-1. Epub 2019 Aug 3. Cancer Immunol Immunother. 2019. PMID: 31375885 Free PMC article. Review.

7

Basis of PD1/PD-L1 Therapies.

Seliger B. Seliger B. J Clin Med. 2019 Dec 8;8(12):2168. doi: 10.3390/jcm8122168. J Clin Med. 2019. PMID: 31817953 Free PMC article. Review.

8

Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer.

Axelrod ML, Wang Y, Xu Y, Sun X, Bejan CA, Gonzalez-Ericsson PI, Nunnery S, Bergman RE, Donaldson J, Guerrero-Zotano AL, Massa C, Seliger B, Sanders M, Mayer IA, Balko JM. Axelrod ML, et al. Among authors: seliger b. Cancer Res Commun. 2022 May;2(5):286-292. doi: 10.1158/2767-9764.CRC-22-0023. Epub 2022 May 4. Cancer Res Commun. 2022. PMID: 36304942 Free PMC article.

9

Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration.

Seliger B, Fedorushchenko A, Brenner W, Ackermann A, Atkins D, Hanash S, Lichtenfels R. Seliger B, et al. Clin Cancer Res. 2007 Jan 1;13(1):27-37. doi: 10.1158/1078-0432.CCR-06-0824. Clin Cancer Res. 2007. PMID: 17200335

10

Expression of neutral endopeptidase (NEP/CD10) on pancreatic tumor cell lines, pancreatitis and pancreatic tumor tissues.

Erhuma M, Köbel M, Mustafa T, Wulfänger J, Dralle H, Hoang-Vu C, Langner J, Seliger B, Kehlen A. Erhuma M, et al. Among authors: seliger b. Int J Cancer. 2007 Jun 1;120(11):2393-400. doi: 10.1002/ijc.22252. Int J Cancer. 2007. PMID: 17294442 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

388 results

Search Page